Brigitte Honhon

Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study

Robert L. Coleman, Domenica Lorusso, Christine Gennigens et al. · The Lancet Oncology · 2021 · 367 citations

Tisotumab Vedotin, Cervical Cancer, Metastatic Cervical Cancer +8

Phase I/II study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancer

J-P. Machiels, Christine Sempoux, Pierre Scalliet et al. · Annals of Oncology · 2007 · 146 citations

Surgical Oncology, Radiation Therapy, Phase I/ii Study +8

Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: the RadiOxCape study

J-P. Machiels, Lionel Duck, Brigitte Honhon et al. · Annals of Oncology · 2005 · 131 citations · Full text

Radioxcape Study, Radiation Therapy, Medicine +8

Prospective Randomized Study Comparing Docetaxel, Estramustine, and Prednisone With Docetaxel and Prednisone in Metastatic Hormone-Refractory Prostate Cancer

Jean‐Pascal Machiels, F Mazzeo, Marylène Clausse et al. · Journal of Clinical Oncology · 2008 · 87 citations · Full text

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

Ignace Vergote, Giovanni Scambia, David M. O’Malley et al. · The Lancet Oncology · 2019 · 85 citations · Full text

Advanced Ovarian Cancer, Medicine, Pharmacology +9